Shenzhen Chipscreen Biosciences Co., Ltd (Chipscreen Biosciences, Shanghai: 688321) was established in March 2001, and has currently become a leading enterprise in developing and manufacturing small molecule innovative medicines in China.
CHIPSCREEN BIOSCIENCES puts as the first priority to meet unmet clinical needs. It insists on “original, safe, excellent and effective China,” and is dedicated in providing patients with affordable innovative therapeutic drugs.
CHIPSCREEN BIOSCIENCES has utilized its proprietary chemical genomics-based discovery platform to successfully develop a portfolio of clinical and preclinical stage programs in a number of therapeutic areas.
CHIPSCREEN BIOSCIENCES has become a four-in-one modern biotech group company, which currently has headquarter / research and development center / GMP production base in Shenzhen, a regional headquarter / research and development center / GMP production base in Chengdu, as well as Beijing clinical research center and Shanghai commercial center.
Till now, the company has developed a number of original new drug pipelines for tumors, diabetes, and endocrine and autoimmune diseases.
|Full name||Shenzhen Chipscreen Biosciences Co., Ltd|
|STAR Theme||Biological Medicine|
|Has weighted voting rights structure?||No|
|Earnings Per Share||0.09||0.07||0.02|
|R&D expenditure as a % of operating revenue||55.85%||62.01%||60.52%|
|Total Owners' Equity||476.90||450.56||213.40|
|Net Cash Flows-Operating||22.78||2.73||59.77|
|Net Cash Flows-Investing||-13.33||-196.09||-135.60|
|Net Cash Flows-Financing||17.95||192.21||141.60|
|Name||No. of Shares Held (mn)||% of Shares Held|
|LAV One (Hong Kong) Co., Limited||25.36||6.1864%|
|Vertex Technology Fund (Ⅲ) Ltd||23.85||5.8179%|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.